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ABSTRACT 39 
The Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is a sequence-specific 40 
DNA binding protein which plays an essential role in viral episome replication and 41 
segregation, by recruiting the cellular complex of DNA replication onto the origin (oriP) 42 
and by tethering the viral DNA onto the mitotic chromosomes. Whereas the mechanisms 43 
of viral DNA replication are well documented, those involved in tethering EBNA1 to the 44 
cellular chromatin are far from being understood. Here, we have identified Regulator of 45 
Chromosome Condensation 1 (RCC1) as a novel cellular partner for EBNA1. RCC1 is 46 
the major nuclear guanine nucleotide exchange factor (RanGEF) for the small GTPase 47 
Ran enzyme. RCC1, associated with chromatin, is involved in the formation of RanGTP 48 
gradients critical for nucleo-cytoplasmic transport, mitotic spindle formation, and 49 
nuclear envelope reassembly following mitosis. Using several approaches, we have 50 
demonstrated a direct interaction between these two proteins and found that the EBNA1 51 
domains responsible for EBNA1 tethering to the mitotic chromosomes are also involved 52 
in the interaction with RCC1. The use of an EBNA1 peptide array confirmed the 53 
interaction of RCC1 with these regions and also the importance of the N-terminal region 54 
of RCC1 in this interaction. Finally, using confocal microscopy and FRET analysis to 55 
follow the dynamics of interaction between the two proteins throughout the cell cycle, we 56 
have demonstrated that EBNA1 and RCC1 closely associate on the chromosomes during 57 
metaphase, suggesting an essential role for the interaction during this phase, perhaps in 58 
tethering EBNA1 to mitotic chromosomes. 59 
 60 
INTRODUCTION 61 
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus associated with several human cancers 62 
(Crawford, 2001). Following primary infection, the virus persists in a life-long, latent state in 63 
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memory B cells, with intermittent viral production occurring in the oropharynx. Ex vivo, EBV 64 
has the capacity to induce growth transformation of resting primary human B-lymphocytes, 65 
leading to the establishment of lymphoblastoid cell lines (LCLs). In such cell lines, only a 66 
small number of viral genes are expressed which act in concert to induce and maintain 67 
continuous cell proliferation and survival (Kieff & Rickinson, 2007).  68 
In latently infected cells, the EBV genome persists as a multicopy, covalently closed, 69 
double-stranded, nuclear episome. When cells proliferate, these episomes replicate once per 70 
cell-cycle during S phase, using the cellular DNA-replication machinery and are subsequently 71 
equally segregated to the daughter cells, such that a constant copy number of EBV genomes is 72 
maintained through cell divisions (Adams, 1987; Nanbo et al., 2007; Yates & Guan, 1991). 73 
Both replication and segregation depend on the presence of two viral elements, the EBV cis-74 
acting origin of plasmid replication (oriP) and the viral protein EBNA1 (Yates et al., 1984, 75 
1985). oriP is composed of two functional elements: the dyad symmetry (DS) element and the 76 
family of repeats (FR) (Reisman et al., 1985). Both contain recognition sites for the EBNA1 77 
protein. The DS element, which comprises four EBNA1 binding sites arranged in pairs, is 78 
required for DNA replication initiation (Rawlins et al., 1985; Reisman et al., 1985; 79 
Wysokenski & Yates, 1989; Chaudhuri et al., 2001; Ritzi et al., 2003; Schepers et al., 2001). 80 
The FR element consists of an array of twenty imperfect 30 bp repeats, each one containing 81 
an 18 bp EBNA1 binding site (Rawlins et al., 1985; Reisman et al., 1985). FR functions by 82 
tethering the viral episomes to human metaphase chromosomes via EBNA1 (Sears et al., 83 
2003, 2004; Wu et al., 2000, 2002) and this ensures the stable retention of oriP-episomes 84 
within the cells (Kirchmaier & Sugden, 1995; Little & Schildkraut, 1995; Nanbo et al., 2007). 85 
FR is also required for EBNA1-dependent tethering of EBV genomes to specific 86 
perichromatic regions of host chromosomes during interphase (Deutsch et al, 2010) which 87 
appears to be essential for efficient replication of the episome (Hodin et al., 2013).  88 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
 5 
EBNA1 is a homo-dimeric DNA-binding protein that recognises an 18 bp palindromic 89 
sequence via its C-terminal domain (residues 459-607 have been co-crystallised with DNA) 90 
(Ambinder et al., 1990, 1991; Bochkarev et al., 1996; Frappier & O’Donnell, 1991; Jones et 91 
al., 1989; Rawlins et al., 1985; Shah et al., 1992). ChIPseq analyses have shown that, in 92 
addition to binding the DS and FR regions of oriP, EBNA1 binds multiple sites in the host 93 
genome (Lu et al., 2010; Tempera et al., 2015). Independently of its C-terminal-specific 94 
DNA-binding domain, EBNA1 can associate with chromatin throughout the cell cycle via its 95 
N-terminal half. This N-terminal region carries two domains, called Linking Regions 1 (LR1: 96 
aa 40-89) and 2 (LR2: aa 325-379) which confer intramolecular “linking” between EBNA1-97 
DNA complexes as revealed by electrophoretic mobility shift assays (Mackey et al., 1995). 98 
Each of these domains consists of a region rich in arginine and glycine (RGG-rich region: 99 
GR1 and GR2 respectively) and a unique region (UR1 and UR2 respectively). The RGG-rich 100 
regions possess intrinsic AT-hook activity allowing binding to AT-rich DNA (Sears et al., 101 
2003, 2004). These regions have been found to be important for EBNA1 replication and 102 
transcription activity (Mackey & Sugden, 1999) and to play an essential role in tethering 103 
EBNA1 to cellular DNA during interphase (Coppotelli et al., 2011; Coppotelli et al., 2013). 104 
EBNA1 attachment to metaphase chromosomes has been mapped to three independent 105 
chromosome binding sites (CBS) - CBS-1 (aa 72 to 84), CBS-2 (aa 328 to 365) and CBS-3 106 
(aa 8 to 54) - that correlate well with the ability of EBNA1 to confer plasmid maintenance 107 
(Kanda et al., 2001; Maréchal et al., 1999; Wu et al., 2002). However, the mechanisms 108 
responsible for EBNA1 interaction with mitotic chromosomes are still unclear. It has been 109 
proposed that the AT-hook structures within the LR1/LR2 regions could be directly 110 
responsible for EBNA1 attachment to the chromosomes (Kanda et al., 2013; Sears et al., 111 
2004). Interestingly, HMGA1a a cellular chromatin-binding protein which associates with 112 
chromatin through its AT-hook domains, or histone H1, can functionally replace the amino 113 
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terminus of EBNA1 both in oriP plasmid replication and partitioning of the viral episome 114 
(Hung et al., 2001; Sears et al., 2003; Thomae et al., 2008). EBNA1 may also interact with 115 
chromatin through protein-protein interactions with one or several cellular partners. hEBP2 116 
(human Epstein-Barr Binding Protein 2) was the first of the sort identified. (Kapoor et al., 117 
2005; Nayyar et al., 2009; Wu et al., 2000). hEBP2 binds to the LR2 region of EBNA1 (Shire 118 
et al., 1999), which also corresponds to the CBS-2 region. In a yeast model, hEBP2 was 119 
required (in the presence of EBNA1) for the maintenance of a plasmid carrying the EBV FR 120 
sequence (Kapoor et al., 2001, 2003). However, a recent study demonstrated that hEBP2 and 121 
EBNA1 do not interact during mitosis in living mitotic cells, suggesting that the involvement 122 
of hEPB2 might not be direct (Jourdan et al., 2012; Frappier, 2012), or that it might have 123 
another role. More recently, HMGB2 (high-mobility group box 2), a well known chromatin 124 
component, has been identified as a new partner for EBNA1 (Jourdan et al., 2012). EBNA1 125 
interacts with HMGB2 on chromatin during interphase and mitosis, and its depletion partially 126 
alters EBNA1 association with the chromosomes. However, HMGB2 depletion is not 127 
sufficient to alter EBV episome maintenance in Raji cells (Jourdan et al., 2012). Taken 128 
together, these results suggest that several mechanisms cooperate to promote EBNA1 129 
association with the chromosomes throughout mitosis and maintenance of the EBV genome 130 
within proliferating cells.  131 
In order to identify novel proteins that could play a role in EBNA1 chromosomal 132 
binding, we performed a yeast two-hybrid screen. From this screen, we identified Regulator 133 
of Chromosome Condensation 1 (RCC1), a major nuclear guanine nucleotide exchange factor 134 
(RanGEF) for the small GTPase Ran enzyme. In its association with chromatin, RCC1 is 135 
involved in the formation of RanGTP gradients critical for nucleo-cytoplasmic transport 136 
(Riddick & Macara, 2005), mitotic spindle formation and nuclear envelope reassembly after 137 
mitosis (Askjaer et al., 2002; Bamba et al., 2002). RCC1 is a ubiquitous nuclear protein 138 
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structured as a seven bladed propeller with unstructured small N- and C-terminal tails 139 
(Renault et al., 1998). RCC1 directly interacts with histones H2A/H2B (Nemergut et al., 140 
2001) and its structure (bound to Ran and the nucleosomes) has been solved: one face of the 141 
protein binds to Ran (Renault et al., 2001) whereas binding to chromatin involves the N-142 
terminal tail of the protein as well as loop region in the fourth blade of its β-propeller 143 
(England et al., 2010; Makde et al., 2011). RCC1 is modified in cells by removal of the initial 144 
N-terminal methionine and mono-, di- or tri-methylation of the new N-terminal residue 145 
(serine 2 in human). This modification is present throughout the cell cycle and is necessary 146 
for stable chromatin association and normal mitosis (Chen et al., 2007). The association of 147 
RCC1 with chromatin in interphase nuclei and mitotic chromosomes is highly dynamic 148 
(Cushman et al., 2004; Li et al., 2003) and regulated by its interaction with Ran (Hao & 149 
Macara, 2008; Zhang et al., 2002). It is also regulated in a cell cycle dependent manner by 150 
various mechanisms including interaction with Ran-GTP-binding protein 1 (RanBP1) (Zhang 151 
et al., 2014) and phosphoinositide 3-kinase beta (PI3Kβ) (Redondo-Muñoz et al., 2015). A 152 
role of phosphorylation of serine 2 at the N-terminus of RCC1 has also been suggested but 153 
remains controversial (Bierbaum & Bastiaens, 2013; Hutchins et al., 2004; Li & Zheng, 154 
2004).  155 
Due to its ability to interact with chromatin, especially through mitosis during which the 156 
interaction is stabilized, RCC1 appears to be a good candidate to promote the association of 157 
EBNA1 with chromatin. We have now confirmed the interaction between EBNA1 and RCC1 158 
using various in vitro and ex vivo assays. We have demonstrated that this interaction is direct 159 
and characterized the domains involved. Finally, we found that although the proteins 160 
colocalized throughout the cell cycle, they only closely interact during metaphase, strongly 161 
suggesting a role for RCC1 in stabilizing the interaction between EBNA1 and the chromatin 162 
at this phase of the cell cycle.  163 
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Deletion of EBNA1 AT-hook motifs only partially modify its localization to the 166 
metaphasic chromosomes.  167 
EBNA1 has been suggested to directly bind to AT-rich regions of the chromosomal DNA via 168 
AT-hook motifs located within the LR1/GR1 and LR2/GR2 regions (Sears et al., 2004). In 169 
particular, fusion proteins between mCherry and various combinations of the EBNA1 regions 170 
containing AT-hook motifs, efficiently associated with chromosomes (Kanda et al., 2013). 171 
However, the effect of specific deletion of these AT-hook motifs - in the context of the whole 172 
protein - on its association with cellular chromosomes has never been tested. We therefore 173 
generated derivatives of GFP-EBNA1 with either aa 40 to 53 (deleting most of GR1) or 326 174 
to 358 (deleting two thirds of GR2) or both regions deleted (Fig. 1A) and tested their capacity 175 
to bind mitotic chromosomes and activate transcription. Association with chromosomes was 176 
first analysed by confocal microscopy, following transfection of HeLa cells with expression 177 
plasmids for GFP-EBNA1 or the mutated derivatives. Deletion of the GR regions led to the 178 
appearance of a faint diffuse staining of the cell nuclei which was more accentuated in the 179 
double mutant (Fig. 1B). However, even in the double mutant, a large proportion of the 180 
protein remained localized to the metaphasic chromosomes. This suggests that the AT-hook 181 
motifs are not the sole domains responsible for EBNA1 attachment to the chromosomes 182 
during mitosis. Second, we performed a FRAP analysis during cell interphase to 183 
comparatively evaluate the mobility of each protein. The half-time of fluorescence recovery 184 
of the EBNA1 GR-deletion mutants, especially that of the double mutant, was strongly 185 
diminished as compared with GR-wild type EBNA1, indicating a higher mobility of proteins 186 
lacking the AT-hook motifs (Fig. 1C). Finally, to complete the characterization of these 187 
mutants, we tested their transactivation ability since LR1 and LR2 regions were previously 188 
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reported to be important for transcriptional activation (Mackey & Sugden, 1999). The single 189 
GR deletion mutants appear to activate LUC expression from the pGL2-FR-TK-LUC reporter 190 
construct to similar levels as GR-wild type (Fig. 1D). By contrast the double mutant shows 191 
significant reduction in transcriptional activation through FR. Taken together, these results 192 
support a role for these two regions in transcriptional activation, but demonstrate that 193 
although these regions appear to play an important role in chromatin association during 194 
interphase, as could be deduced from the FRAP experiments, they are not absolutely essential 195 
for tethering EBNA1 to the mitotic chromosomes.  196 
EBNA1 interacts directly with RCC1  197 
Since the AT-hook motifs, appear not to be essential for EBNA1 association with mitotic 198 
chromatin, it is likely that one or more cellular partners are involved in mediating the linking 199 
of EBNA1 with the chromosomes. The two cellular proteins which have been previously 200 
found to play a role in this process - hEBP2 and HMGB2 - do not appear to be sufficient to 201 
account for all the properties of EBNA1 during EBV replication and segregation. In order to 202 
identify novel cellular partners of EBNA1, a yeast two-hybrid screen using EBNA1 as bait 203 
was performed. From this screen, Regulator of Chromosome Condensation 1 (RCC1) (gene 204 
ID: 1104), a guanine-nucleotide releasing factor that promotes exchange of Ran-bound GDP 205 
with GTP, was identified. RCC1 plays a key role both in nucleo-cytoplasmic transport and in 206 
the regulation of onset of chromosome condensation in S phase (Hadjebi et al., 2008).  207 
The interaction between EBNA1 and RCC1 was first examined by co-208 
immunoprecipitation from transfected HeLa cells (Fig. 2A). Myc-tagged RCC1 specifically 209 
co-immunoprecipitated with Flag-tagged EBNA1. Consistently, in a reverse experiment, 210 
Myc-tagged EBNA1 specifically co-immunoprecipitated with Flag-tagged RCC1.  211 
To assess if the interaction is direct, an in vitro GST-pulldown assay was performed 212 
using both GST-RCC1 and 6xhis-EBNA1 produced in bacteria and purified. 6xhis-EBNA1 213 
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was incubated with similar amounts of GST or GST-RCC1 proteins bound to glutathione 214 
sepharose beads. EBNA1 was efficiently retained on GST-RCC1 beads but not on GST alone, 215 
which strongly suggests that a direct interaction occurs between EBNA1 and RCC1 (Fig. 2B).  216 
EBNA1 binds RCC1 via domains previously reported to be essential for chromosome 217 
binding of the protein 218 
EBNA1 interaction with mitotic chromosomes has been reported to be dependent on three 219 
regions: CBS-1 (aa 72 to 84), CBS-2 (aa 328 to 365) and CBS-3 (aa 8 to 54) (Fig. 3A) (Kanda 220 
et al., 2001; Maréchal et al., 1999; Wu et al., 2002). We thus investigated the involvement of 221 
these regions in the interaction with RCC1. For this, a series of GFP-tagged EBNA1 deletion 222 
mutants were expressed in HeLa cells and the lysates incubated with GST-RCC1-bound 223 
beads. Deletion mutants containing either CBS-1/CBS-3 (EBNA1 8-92), CBS-2 (EBNA1 224 
323-410) or both (EBNA1 8-410) were all able to interact with RCC1, whereas EBNA1 377-225 
641 with both regions deleted, showed considerably reduced interaction (Fig. 3B). This 226 
preferential interaction of RCC1 with the CBS domains of EBNA1 supports a putative role 227 
for RCC1 in EBNA1’s targeting to metaphase chromosomes. Surprisingly however, deletion 228 
of region 326 to 376 completely abrogated the interaction with RCC1 (Fig. 3C), even though 229 
the CBS-1/-3 domains still present in this mutant were sufficient for interaction with RCC1 in 230 
mutant EBNA1 8-92 (Fig. 3B). This suggests that EBNA1 Δ326-376 protein’s general 231 
topology may be altered such that the CBS-1/-3 domains are no longer accessible to interact 232 
with RCC1.  233 
We also tested the capacity of the GR-deleted mutants used in Figure 1, to interact with 234 
RCC1 (Fig. 4). Although deletion of each region individually did not prohibit interaction with 235 
RCC1, deletion of both motifs had a dramatic effect. This suggests that at least one intact GR 236 
sub-region is required for the interaction with RCC1.  237 
Taken together, these results indicate that the EBNA1 interaction domains with RCC1 238 
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overlap closely with the previously characterized EBNA1 chromosome binding regions. 239 
However, it is to be noted that mutant Δ40-53/Δ326-358 with GR1 and most of GR2 deleted, 240 
was still - at least partially - associated with the mitotic chromosome, whereas no interaction 241 
with RCC1 could be detected in the GST-pulldown assay. Thus, although RCC1 is likely to 242 
contribute to EBNA1 association with metaphasic chromosomes, it is probably not the only 243 
factor involved. 244 
The RCC1 N-terminal tail is essential for RCC1 interaction with EBNA1  245 
RCC1 is composed of small N-terminal and C-terminal unstructured tails surrounding a 246 
seven-bladed propeller structure (Makde et al., 2011) (Fig. 5A). Due to the highly structured 247 
central domain of the protein, introducing large mutations into this region would likely 248 
disorder the entire structure. Therefore, a single RCC1 mutant, RCC1 Δ1-20, with the N-249 
terminal tail deleted, was generated. Further, the N-terminal tail was cloned in fusion with 250 
GST. GST-pulldown using transfected HeLa cell extracts were performed with these proteins 251 
(Fig. 5B). Interestingly, we found that EBNA1 interacted strongly with the N-terminal tail of 252 
RCC1 and very inefficiently with the rest of the protein. To further map the interaction region, 253 
smaller deletions within the N-terminal extremity of RCC1 were introduced. Deletion of aa 254 
11-15 or 16-20 did not significantly modify the interaction with EBNA1, in contrast to 255 
deletions of aa 1-5 and 6-10 which both impaired the interaction. These results suggest that 256 
the 10 first amino acids of the RCC1 N-terminal tail are important for the interaction of RCC1 257 
with EBNA1.  258 
Peptide array analysis confirms the RCC1 interaction with the CBS-3/-1 and CBS-2 259 
domains and also defines potential supplementary RCC1 interaction regions in the C-260 
terminal moiety of the protein. 261 
With the aim to delimit the domains of EBNA1 involved in the interaction with RCC1 more 262 
precisely, a peptide array analysis was undertaken. A library of overlapping peptides (25-263 
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mers), each shifted by 5 amino acids across the entire sequence of EBNA1 (including the 264 
GAr) was immobilised onto membranes and probed with recombinant GST-RCC1 full length 265 
(FL) and mutants (Fig. 6). Probing the EBNA1 peptide array with FL GST-RCC1 revealed 266 
intermediate to strong binding to peptides covering regions that encompass both GR repeats 267 
of EBNA1 as well as CBS-1 (aa 72 to 84) and CBS-3 (aa 8 to 54), which is consistent with 268 
our GST-pulldown mapping. It is interesting to note that the strongest interacting regions 269 
overlap with the AT-hook domains whose deletion in mutant EBNA1Δ40-53/Δ326-358, 270 
completely abrogates binding in our GST-pull down assay (Fig. 4). Thus, there is good 271 
agreement between the GST-pull down assay and the peptide array analysis. Moreover, the 272 
peptide analysis revealed the presence of unexpected binding regions in the central and C-273 
terminal moiety of EBNA1: a first region between aa G371-E435 lies between the known 274 
binding sites for CK2 and USP7 and is well conserved in EBV EBNA1 isolates  (Hussain et 275 
al., 2014); a second region incorporates the C-terminal tail of the protein, rich in negatively 276 
charged residues. Reprobing the array with GST, indicated that the binding observed for GST-277 
RCC1 was specific to RCC1. 278 
When a second array was probed with GST-RCC1Δ1-20, binding was observed for 279 
largely the same set of peptides as for full length RCC1, but much weaker, with the notable 280 
exception of the C-terminal tail peptides, which showed no binding. Therefore, consistent 281 
with our GST-pulldown mapping, RCC1 with its N-terminal 20 aa deleted, only weakly 282 
interacts with EBNA1. This suggests that either the N-terminal region of RCC1 is the primary 283 
mediator of binding or that it is required for correct folding of full-length RCC1 to enable 284 
binding to EBNA1, or possibly both.  285 
To distinguish between these possibilities, the second array was stripped and re-probed 286 
with just the N-terminal region of RCC1 fused to GST. GST-RCC1 1-20 showed intermediary 287 
binding to the C-terminal tail peptides and strong binding to peptides covering region R396 to 288 
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E435. However, strong binding was not observed with peptides localised in the N-terminal 289 
half of EBNA1 although these were strongly bound by full-length RCC1. This suggests that 290 
residues 1-20 of RCC1 contribute to the conformation of RCC1, or otherwise promote the full 291 
interaction, but may not completely comprise the binding site. 292 
Regarding the strongest binding region identified for RCC1 1-20, analysis of the 293 
EBNA1 amino acid sequence reveals that the stretch of residues in common between EBNA1 294 
peptides interacting strongly with GST-RCC1 1-20 lies between aa 411 to 420 295 
(EADYFEYHQE). This region contains 4 negatively-charged residues. By contrast, the N-296 
terminal region of RCC1 (MSPKRIAKRRSPPADAIPKS) contains 6 positively charged 297 
residues and one negatively charged residue. It is therefore possible that the interaction of 298 
RCC1 with these EBNA1 peptides is largely charge-based and possibly an artefact of the 299 
array approach, if these stretches are not normally accessible in the folded protein. To explore 300 
this possibility, a new array was generated with a series of mutated peptides spanning residue 301 
401 to 430 and probed with GST-RCC1 1-20 (Supplementary Figure 1). This revealed that 302 
indeed charge is critical to the binding, such that replacement of the 4 charged residues (E411, 303 
D413, E416, E420) completely abrogated binding, however F415 and Y414 were also found to be 304 
key for the interaction. This region was thus a candidate for being a core binding site between 305 
the N-terminal region of RCC1 and EBNA1. However, an EBNA1 mutant deleted for this 306 
region (EBNA1Δ411-420) still interacted with RCC1 in a GST-pulldown assay (Fig. 4B, lane 307 
5). Therefore, it appears that this region is not required for stabilizing the EBNA1-RCC1 308 
interaction in vitro. However, it cannot be ruled out that it might play a role in the interaction 309 
in vivo, in a context where RCC1 is associated with chromatin.  310 
EBNA1 interacts with RCC1 localized to chromatin during mitosis 311 
In order to determine the subcellular localization of the two proteins in living cells, 312 
several fluorescent-tagged forms of EBNA1 and RCC1 were expressed in HeLa cells and 313 
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observed by live cell imaging during interphase and mitosis. The EGFP-RCC1 and EBNA1-314 
RFP proteins colocalize almost perfectly in living cells during interphase and throughout 315 
mitosis (Fig. 7): during interphase the proteins colocalize throughout the nucleoplasm, with 316 
the exception of the nucleolus from which RCC1 is completely excluded and where weak 317 
staining is observed for EBNA1. During prophase and metaphase, both EBNA1 and RCC1 318 
appear to be associated with the mitotic chromosomes. Similar observations were made in 319 
cells coexpressing other pairs of EGFP- and RFP-tagged forms of the proteins (data not 320 
shown). 321 
To confirm that EBNA1 interacts with RCC1 in living cells we performed a Förster 322 
resonance energy transfer (FRET) analysis. FRET is a nonradioactive energy transfer that can 323 
occur when a donor and a compatible acceptor fluorophore are located at less than 10 nm 324 
from each other. FRET efficiency relies on the relative position and distance of the donor and 325 
acceptor fluorophores, which can be affected by the position of the fluorophore in a fusion 326 
protein. Therefore, both the following pairs of fusion proteins: EGFP-RCC1/EBNA1-RFP and 327 
EGFP-EBNA1/RFP-RCC1 were tested. No significant FRET was observed with the EGFP-328 
RCC1/EBNA1-RFP pair. However, the EGFP-EBNA1/RFP-RCC1 pair revealed clear FRET 329 
activity during both interphase and metaphase (Fig. 8). During interphase, it is interesting to 330 
note that although the proteins colocalize throughout the nucleoplasm (Fig. 7), they were only 331 
in close interaction at the periphery of the nucleus (Fig. 8). Only very weak interaction was 332 
observed during prophase. By contrast, strong interaction was observed between the two 333 
proteins on metaphasic chromosomes. Taken together, these results suggest that the 334 
interaction between RCC1 and EBNA1 is highly dynamic through the cell cycle. The strong 335 
FRET signal observed specifically on metaphasic chromosomes supports a role for RCC1 in 336 
stabilizing the EBNA1 interaction with the chromosomes during mitosis. 337 
 338 
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DISCUSSION 339 
The mechanisms by which EBNA1 tethers the EBV genome to mitotic chromosomes are far 340 
from understood. The AT-hook regions of the protein have been proposed to play a major role 341 
in EBNA1 chromosome binding activity and episomal maintenance (Sears et al., 2003, 2004). 342 
The use of netropsin, a small molecule that binds to the minor groove of AT-rich DNA, leads 343 
to the loss of EBV genomes from cells, supporting the role of the AT-hooks in episomal 344 
maintenance (Chakravorty & Sugden, 2015). However, we have found that deletion of the 345 
EBNA1 AT-hook regions does not abrogate EBNA1’s general targeting to metaphasic 346 
chromosomes. This result is consistent with a previous analysis revealing three independent 347 
CBS regions (Marechal et al., 1999). In effect, specific deletion of the AT-hook domains 348 
leaves CBS-1 (aa 72 to 84) intact. Therefore these data reinforce the idea of alternative or 349 
complementary mechanisms of recruitment of EBNA1 to the metaphasic chromosomes, 350 
possibly via the interaction with cellular chromatin binding factors.  351 
Here, we have identified RCC1 as a novel mediator of EBNA1 interaction with 352 
metaphase chromosomes. We have characterized the interaction between EBNA1 and RCC1 353 
by various methods. Importantly, by performing an in vitro assay using both proteins purified 354 
from bacteria, we have demonstrated that the two proteins can interact directly. Up to now, 355 
however, we have not been able to perform a successful co-immunoprecipitation with 356 
endogenous proteins. One explanation, other than a possible interference of antibodies with 357 
the interaction and the low level of expression of EBNA1, is the small amount of cells from 358 
the total population undergoing mitosis - the phase of the cell cycle in which our FRET 359 
experiments demonstrate a close interaction between the proteins.   360 
Characterization of the interaction domains revealed that the RCC1 interaction domains 361 
of EBNA1 closely overlap with the CBS regions of the protein, known to be important for 362 
tethering EBNA1 to the chromosomes (Maréchal et al., 1999). Accordingly, we have found 363 
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that region 8-92 which includes both CBS-3 and CBS-1, and region 323-410 which includes 364 
CBS-2, can interact independently with RCC1. Surprisingly, however, deletion of CBS-2 in 365 
mutant Δ326-376 previously found to impair hEBP2 interaction as well as oriP plasmid 366 
maintenance and mitotic localization (Shire et al., 1999; Wu et al., 2000), completely 367 
abolished EBNA1 interaction with RCC1. This latter result is not consistent with the finding 368 
that the CBS-3/-1 region (still present in this mutant) is sufficient alone to mediate the 369 
interaction with RCC1. This suggests that the conformation or accessibility of the CBS-3/-1 370 
region is compromised in this mutant, affecting various functions of the protein without 371 
necessarily reflecting the direct involvement of the deleted region.  372 
Since the EBNA1 mutant with the two AT-hook domains deleted, appears to localize to 373 
chromatin both during interphase and through mitosis (which had not previously been tested), 374 
mechanisms other than the interaction of EBNA1 with AT-rich regions of DNA are likely to 375 
be required. However, deletion of the two AT-hook domains also affected the interaction with 376 
RCC1, suggesting that still other factors are involved. Another chromatin binding protein, 377 
HMGB2, was previously identified as an EBNA1 interacting factor (Jourdan et al., 2012). 378 
HMGB2 could thus be responsible for targeting EBNA1 to the chromatin, in the absence of 379 
both direct interaction with DNA (via the AT-hooks) and interaction with RCC1. To 380 
corroborate such an hypothesis it would be interesting to know more precisely where HMGB2 381 
binds within EBNA1. Alternatively, another as yet unidentified partner could be involved in 382 
the process. These possibilities are not mutually exclusive, indeed EBNA1 may employ 383 
multiple mechanisms to tether the viral genome to chromatin and to associate with the 384 
chromatin independently of the viral genome, through the different stages of the cell cycle and 385 
under various conditions. 386 
Regarding the domains of RCC1 involved in the interaction with EBNA1, the N-387 
terminal flexible region of RCC1 was identified as an essential domain. Interestingly, this N-388 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
 17 
terminal tail, and in particular the serine at position 2, is the site of post-transcriptional 389 
modifications (both α-N-methylation and phosphorylation) that are important for stable 390 
chromatin association and regulation of RCC1’s NLS interaction with importins α and β 391 
(Chen et al., 2007; Li & Zheng, 2004). Such modifications of RCC1 N-terminal tail within 392 
mammalian cells could modulate or even prevent the interaction between the two proteins. 393 
Conversely, since these modifications have been suggested to play an important role in the 394 
mobility of RCC1 during metaphase and in its stabilization on the chromatin (Hutchins et al., 395 
2004; Li & Zheng, 2004), EBNA1’s interaction with these regions could affect the dynamics 396 
of RCC1’s interaction with chromatin.  397 
Use of EBNA1 peptide arrays permitted a more detailed mapping of the EBNA1 398 
interaction regions with respect to full length RCC1 as well as the N-terminal tail. Interaction 399 
of full-length RCC1 (and to lesser extent the N-terminal tail of RCC1 alone) with the CBS-1/-400 
3 and CBS-2 regions of EBNA1 was confirmed. In addition, two other regions of EBNA1 401 
were identified that might be involved in the interaction: the C-terminal tail, and a negatively 402 
charged region located between the previously characterized CK2 and USP7 binding sites. 403 
Interestingly, these two regions (particularly the latter) are recognised by RCC1’s N-terminal 404 
tail. In particular, the N-terminal tail of RCC1 critical for the interaction specifically contacts 405 
a region of EBNA1 - DYFEYHQE - located between aa 413 and 420. When set in the context 406 
of an in silico structural model of full-length EBNA1 (Hussain et al., 2014), this domain 407 
appears to be located in a region that resembles a small pocket. This could potentially 408 
accommodate the N-terminal region of RCC1, facilitating further interactions between the 409 
CBS domains of EBNA1 and the seven-propeller helix of RCC1, and hence stabilising the 410 
interaction between the two proteins. However, deletion of this domain does not preclude 411 
binding of EBNA1 and RCC1 in the in vitro assays used here and we cannot exclude that it 412 
may reflect artifactual binding to a site that is not normally accessible to RCC1. 413 
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With regard to the dynamics of interaction between the two proteins in live cells, the 414 
combination of colocalization experiments in live cells and FRET analysis reveals that the  415 
two proteins colocalize with the chromatin throughout the cell cycle. However, their 416 
proximity varies according to the location within the cell nucleus as well as the phase of the 417 
cell cycle: during interphase, although the two proteins appear to be colocalizing throughout 418 
the cell nucleus, FRET could only be observed at the periphery of the nucleus, suggesting that 419 
close interaction between EBNA1 and RCC1 could be linked to the latter being in a different 420 
conformation when actively involved in nucleo-cytoplasmic transport. This result opens up 421 
the possibility that the interaction of EBNA1 with RCC1 could play a role in functions other 422 
than segregation of the viral episome.  423 
Importantly, during mitosis, FRET was mainly observed in metaphase, indicating a 424 
more specific role for the RCC1-EBNA1 interaction at this particular stage of mitosis that 425 
precedes segregation of sister chromatids. This observation, together with the correlation 426 
between EBNA1 regions interacting with RCC1 and EBNA1 domains previously 427 
characterized for their role in chromosome binding and episome maintenance, argues for an 428 
important role of RCC1 in EBV episome tethering to the chromosomes and subsequent 429 
episome maintenance. However, this hypothesis will be difficult to prove directly since RCC1 430 
is an essential protein whose downregulation leads to premature chromosome condensation or 431 
arrest in the G1 phase of the cell cycle (Uchida et al., 1990). The observation that deletion of 432 
the AT-hook domains still permits association of EBNA1 with metaphase chromosomes while 433 
it appears to abrogate interaction with RCC1 in vitro, does not refute the hypothesis. First, the 434 
assay conditions used to detect the interaction in vitro may not be optimum and a weak 435 
interaction between EBNA1 and RCC1 might nevertheless occur in vivo in the absence of the 436 
AT-hook domains. Alternatively, in the absence of an interaction between RCC1 and EBNA1, 437 
alternative mechanisms tethering EBNA1 to the chromatin may act. Of note, depletion of 438 
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HMGB2 was found to affect the stability but not to prevent EBNA1 association with 439 
chromatin, nor did it impact viral genome maintenance, despite the observed interaction 440 
between EBNA1 and HMGB2 on chromatin through mitosis (Jourdan et al., 2012). It is thus 441 
likely that several mechanisms are involved in EBNA1 tethering to the chromatin, 442 
orchestrated to play a role at different stages of the cell cycle to both bring EBNA1 to the 443 
chromatin and stabilize it once there: During interphase, the EBV genomes are distributed to 444 
perichromatic regions of the nucleus in a manner dependent on the FR element and EBNA1 445 
(Deutsch et al., 2010). It has been suggested that the AT-hook domains of EBNA1 could play 446 
an important role in this tethering of the EBV genomes to the chromatin. This hypothesis is 447 
strengthened by the demonstration that HMG1Aa, an AT-hook binding protein can 448 
functionally replace the N-terminal domain of EBNA1 (Sears et al., 2003; Thomae et al., 449 
2008) and by the results of our FRAP analysis showing a higher mobility of EBNA1 with its 450 
AT-hook domains deleted; HMGB2 is associated with EBNA1 on the chromatin during 451 
interphase and more so during mitosis (Jourdan et al., 2012); RCC1 colocalizes with EBNA1 452 
throughout the cell cycle but the interaction appears to be specifically stabilized during 453 
metaphase. Moreover, interaction between EBNA1 and the chromatin could be facilitated by 454 
a direct interaction through the AT-hook domains with nucleosomal DNA. 455 
Finally, it is interesting to note that the ortholog of EBNA1 in KSHV (Kaposi Sarcoma 456 
Herpes Virus), LANA (Latency-Associated Nuclear antigen), directly interacts with H2A-457 
H2B dimers to enable its binding to chromosomes (Piolot et al., 2001). The resolution of the 458 
crystal structure of the nucleosome complexed with the first 23 amino acids of LANA 459 
revealed that the LANA peptide forms a hairpin that interacts with an acidic H2A-H2B region 460 
implicated in the formation of higher order chromatin structure (Barbera et al., 2006). 461 
Interestingly, RCC1 targets the same region of the nucleosomal H2A-H2B dimer as LANA, 462 
and the two proteins have been shown to compete for nucleosome interaction (England et al., 463 
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2010). Thus, whereas LANA directly contacts the H2A-H2B dimer to enable its binding to 464 
the chromosomes, EBNA1 may interact indirectly with the same H2A-H2B dimer through 465 
RCC1. Similar to EBNA1, LANA also interacts with several cellular proteins that appear to 466 
play a role in the tethering of LANA to chromosomes and/or episomal segregation (Krithivas 467 
et al., 2002; Xiao et al., 2010). Thus EBNA1 and LANA have evolved similar but not 468 
identical mechanisms to insure anchorage of the viral episomes onto the chromatin at different 469 
stages of the cell cycle, allowing efficient replication and segregation of the respective viral 470 
genomes.  471 
 472 
METHODS 473 
Cell culture and transfections  474 
HeLa and HEK293T cells were grown at 37°C in DMEM, 10% FCS. Plasmid transfection 475 
was performed using the PEI transfection reagent (Polysciences). 476 
Plasmids 477 
pEGFP-N1-EBNA1ΔGA (aa 8 to 641) has been described previously (Jourdan et al., 2012). 478 
Unless otherwise indicated, all EBNA1 plasmids used were derived from this plasmid and 479 
thus contain EBNA1 deleted for GAr as well as the first 7 N-terminal aa. EBNA1 and RCC1 480 
N-terminal tail deletion mutants were generated by site-directed mutagenesis (QuickChange 481 
Site-Directed Mutagenesis kit, Stratagene). For the two-hybrid screen, ORFs for EBNA1, 482 
EBNA1 8-410 and EBNA1-381Cter were PCR-amplified (KOD Hot Start DNA 483 
Polymerase®, EMD Millipore) cloned first in pDONR207 then into pGBKT7, using the 484 
Gateway recombinational cloning system (Invitrogen). EBNA1 and deletion mutants cloned 485 
into pDEST-Myc, pCI-3xFlag, pDEST15 or pDEST53 were also generated using the Gateway 486 
system. A codon-optimised version of EBNA1-ΔGA was cloned into pET22b (Merck 487 
Millipore) to generate pET22b-EBNA1. The ORF for full-length RCC1 (alpha isoform) was 488 
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transferred from pDONR223-RCC1 (obtained from a human ORFeome library) into pDEST-489 
Myc, pCI-3xFlag or pDESTTM15 (Invitrogen) using the Gateway system. pEGFP-C1-EBNA1 490 
has been described previously (Jourdan et al., 2012). pRFP and pEGFP fusion proteins were 491 
generated by cloning the relevant PCR-amplified ORFs in pRFP-N1, pRFP-C1, pEGFP-N1 or 492 
pEGFP-C1, using the In-Fusion®HD cloning kit (Clontech). All oligonucleotides used are 493 
listed in Supplementary Table 1. 494 
Luciferase Assays 495 
Renilla or Firefly luciferase activities were measured in a VeritasTM Luminometer (Turner 496 
Biosystems) using the Renilla or Firefly Luciferase Assay system (Promega Madison Co).  497 
Yeast two-hybrid screens 498 
The screens were performed as previously described (Bazot et al., 2014) using pGBKT7-499 
EBNA1/-EBNA1-8-410 or -EBNA1-381Cter as bait vectors and a human LCL AD-cDNA 500 
library (Invitrogen). Positive clones were sequenced and identified by automatic BLAST 501 
(Pellet et al., 2010).  502 
Co-immunoprecipitation and western blotting 503 
Cells were lysed in 50 mM Tris-HCl pH 7.5, 150-300 mM NaCl, 1 mM Dithiotreitol (DTT) 504 
and 0.5% Nonidet P-40 plus protease inhibitors. For immunoprecipitation of transiently 505 
expressed Flag-tagged proteins, extracts were incubated with 20 μl of anti-Flag M2 affinity 506 
gel (Sigma) for 4 h at 4°C. After washing, bound proteins were analysed by western blotting, 507 
visualised using ECL (Thermo Fisher Scientific). Antibodies: anti-Flag rabbit polyclonal 508 
antibody (Sigma), anti-His6 mouse monoclonal antibody (Roche Molecular Biochemicals), 509 
anti-c-Myc (9E10) HRP-conjugated antibody (Santa Cruz Biotechnology, Inc). Anti-rabbit 510 
and anti-mouse (HRP)-conjugated antibodies (GE Healthcare) were used as secondary 511 
antibodies.  512 
Production and purification of the 6xhis-EBNA1 protein 513 
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6xhis-EBNA1 was purified from Escherichia coli Rosetta (pLysS) strain transformed with 514 
pET22b-EBNA1. Cells were lysed in 50 mM NaH2PO4, 1 M NaCl, 10 mM imidazole pH 8, 515 
protease inhibitors and 1 mg/ml lysozyme. After sonication, the protein was purified by 516 
gravity-flow chromatography using Ni-NTA agarose beads. Beads were washed with lysis 517 
buffer plus 50 mM imidazole and the proteins eluted in lysis buffer containing 150 mM 518 
imidazole.  519 
In vitro GST-Pulldowns 520 
Glutathione S-Transferase (GST) and GST-fusion proteins were purified from Escherichia 521 
coli BL21 (DE3) codon plus strain extracts, with glutathione-Sepharose 4B beads (GE 522 
Healthcare). Beads carrying the GST or the GST-fusion proteins were equilibrated in MTPBS 523 
(150 mM NaCl, 16 mM Na2HPO4, 4 mM NaH2PO4, 100 mM EDTA, 1% Triton) and 524 
incubated with either purified 6xhis-EBNA1 or transfected cell extracts for 4h in MTPBS. 525 
Beads were washed 5 times in MTPBS and bound proteins analysed by western blotting. 526 
EBNA1 peptides arrays  527 
25mer peptides comprising the entire sequence of EBNA1 (B95.8 strain), with 5 residue shifts 528 
(ie. initiating at residues 1, 6, 11, 16 etc) were synthesized by automatic SPOT synthesis 529 
(Kramer and Schneider-Mergener, 1998) directly onto cellulose membranes using Fmoc (9-530 
fluorel methoxycarbonyl) chemistry and Autospot Robot ASS222 peptide synthetizer (Invatis 531 
Bioanalytical Instruments AG). Arrays were bathed in ethanol and washed for 10 mins in 532 
TBST (50 mM Tris.HCl pH7.5, 150 mM NaCl, 0,05% Tween-20), followed by blocking in 533 
TBST, 5% non-fat milk powder (NFM) for 2 hours at RT and washed again with TBST. 534 
Arrays were probed with purified GST (as control) or GST fusion proteins, at 2 to 5 ug/mL in 535 
TBST, 1% NFM, shaking overnight at 4°C. After washing in TBST, membranes were 536 
incubated with rabbit anti-GST-HRP and the array revealed using ECL (Pierce #32106). To 537 
strip the array membranes for re-probing, they were covered in 60 mM Tris-HCl pH6.8, 20 538 
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mM DTT, 70 mM SDS, at 70°C for 30 min.  539 
Confocal microscopy  540 
HeLa cells were plated onto glass-bottomed dishes for confocal microscopy (Ibidi) and 541 
transfected with expression vectors coding for EBNA1 and RCC1 fused to either EGFP or 542 
RFP. Live cells were analyzed with a Zeiss LSM710 confocal microscope with ZEN software. 543 
GFP and RFP signals were acquired using respectively an argon laser at 488nm and a laser 544 
diode (DPSS) at 561nm. Z-stack series were also acquired for mitotic cells: the most 545 
representative stacks are presented. All analyses were conducted with ImageJ Software.  546 
Fluorescence recovery after photobleaching (FRAP) analysis 547 
Cells used for FRAP acquisition were prepared as for classical microscopy and data collected 548 
using a confocal spinning disk microscope. Same parameters were used to acquire all images. 549 
Regions of interest were photobleached using a 494-nm laser during 510ms at full power. 550 
Images were acquired with an EM gain of 30, 200ms exposure time and a 488-nm laser at 551 
9.5% full power. 5 images were acquired before bleaching then 1 image every 0.5s for 5 552 
seconds, 1 image per second for 1 minute and 1 image every 5 seconds for 30 seconds. 553 
Analysis was performed using ImageJ and EasyFrap software. 554 
Förster resonance energy transfer (FRET) analysis  555 
Cells used for FRET acquisition were prepared as for confocal microscopy and data collected 556 
with an LSM-710 confocal microscope. FRET analysis was performed using the FRET 557 
Analyzer plugin (http://rsb.info.nih.gov/ij/plugins/fret-analyzer/fret-analyzer.htm). Three 558 
tracks were used for the acquisition: EGFP (excitation: GFP, reception: GFP range), RFP 559 
(excitation: RFP, reception: RFP range) and FRET (excitation: GFP, reception: RFP range). 560 
Argon laser and DPSS were used at 2% and 7% power respectively. Gain level was 540 for 561 
the GFP signal and 640 or 690 for the RFP signal. Spectral leakage was measured by 562 
acquisition of 5 images for each track with EGFP or RFP fusions expressed alone. Double 563 
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transfected cells were used for FRET acquisition data. In each case EGFP, RFP and FRET 564 
fluorescent signals were acquired for each track.  565 
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LEGENDS TO FIGURES 783 
Figure 1. Deletion of EBNA1 AT-hook domains drastically affects EBNA1-mediated 784 
transcriptional activation but has only moderate impact on EBV’s association with the 785 
metaphasic chromosomes. (A) Schematic representation of EBNA1 and AT-hook deletion 786 
mutants. Note: deletion coordinates shown are in the context of the GAr deletion (aa 93-325) 787 
and deletion of aa 1-7, incorporated in all constructs. GR: glycine/arginine-rich region; UR: 788 
unique region; GAr: glycine/alanine-repeat region; DBD: DNA-binding domain; NLS: 789 
nuclear localization signal; Ac: acidic. (B) Confocal microscopy analysis of EBNA1 and 790 
EBNA1 mutants during metaphase. HeLa cells were transfected with expression vectors for 791 
either GFP-EBNA1 or GFP-EBNA1 deletion mutants and the localization of the proteins was 792 
assessed in live cells by confocal microscopy. Upper and lower panels correspond to different 793 
individual cells. (C) FRAP analysis of EBNA1 and EBNA1 AT-Hooks deletion mutants 794 
expressed in HeLa cells. Average t1/2 of fluorescence recovery was calculated from a 795 
minimum of 6 cells for each protein from a representative experiment. (D) HEK293T cells 796 
were transfected with the pGL2-FR-TK-Luc reporter plasmid, which contains the EBV FR-797 
element cloned upstream of the Herpes simplex virus thymidine kinase (TK) promoter, either 798 
alone or together with expression vectors for EBNA1 or EBNA1 deletion mutants (as 799 
indicated). Luciferase activity was measured for identical amounts of total protein as 800 
evaluated by Bradford assay. Relative levels of luciferase activity are shown graphically. 801 
Error bars represent standard deviation from three replicate assays. Significant differences 802 
were evaluated by a student test (*** indicate a p value < 0,05; ns: non significant). 803 
 804 
Figure 2. EBNA1 and RCC1 interact directly. (A) Expression plasmids for Flag-RCC1, 805 
Flag-EBNA1ΔGA, Myc-RCC1 and Myc-EBNA1ΔGA were transfected into HeLa cells as 806 
indicated. Cellular extracts were immunoprecipitated with anti-Flag affinity gel and the 807 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
 34 
immunoprecipitated complexes were analysed by western blotting using an anti-Flag 808 
polyclonal antibody or an anti-Myc antibody. Input corresponds to 8% of the cell extract used 809 
for immunoprecipitation. (B) 500 ng of purified 6xhis-EBNA1ΔGA protein were incubated 810 
with similar amounts of purified GST or GST-RCC1 bound to glutathione sepharose beads. 811 
The EBNA1-bound proteins were analysed by western blotting using an anti-his6 MAb. Input 812 
corresponds to 100 ng of purified 6xhis-EBNA1ΔGA. 813 
 814 
Figure 3. EBNA1 regions CBS-3, CBS-1 and CBS-2 are involved in the interaction with 815 
RCC1. (A) Schematic representation of EBNA1. Abbreviations as in Figure 1 and CBS: 816 
chromosome binding sites. (B - C) Expression plasmids for GFP-tagged (B) or Flag-tagged 817 
(C) EBNA1 and EBNA1 deletion mutants, as indicated in the figure (note: protein/deletion 818 
coordinates shown are in the context of the GAr deletion (93-325) and deletion of aa 1-7, 819 
incorporated in all constructs), were transfected into HeLa cells. Cellular extracts were then 820 
incubated with similar amounts of GST or GST-RCC1 proteins bound to glutathione 821 
sepharose beads. Bound proteins were analysed by western blotting using either an anti-GFP 822 
antibody (B) or an anti-Flag antibody (C) as probes. Input corresponds to 10% of cell extract 823 
used for the GST-pulldown.  824 
 825 
Figure 4. Combined deletion of GR1 and GR2 drastically affects interaction with RCC1. 826 
(A) Schematic representation of EBNA1 and EBNA1 deletion mutants. (B) Expression 827 
plasmids for GFP-tagged EBNA1 and EBNA1 deletion mutants, as indicated in the Figure, 828 
were transfected into HeLa cells. Cellular extracts were then incubated with similar amounts 829 
of GST or GST-RCC1 proteins bound to glutathione sepharose beads. Bound proteins were 830 
analysed by western blotting using an anti-GFP antibody as probe. Input corresponds to 10% 831 
of cell extract used for the GST-pulldown.  832 
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 833 
Figure 5. RCC1 interacts with EBNA1 via its 20 amino acid N-terminal tail.  834 
(A) Schematic representation of RCC1. N- and C- terminal regions of RCC1 surround a seven 835 
bladed propeller domain (in grey). Residues 1 to 27 corresponding to the N-terminal tail are 836 
detailed below. The bi-partite NLS and phosphorylation sites on Ser 2 and 11 are indicated as 837 
well as the α-N-tri-methylation of serine 2 that follows cleavage of the first methionine 838 
indicated in brackets. (B) Expression plasmids for Flag-EBNA1 were transfected into HeLa 839 
cells and cellular extracts incubated with similar amounts of GST, GST-RCC1 or GST-RCC1-840 
deletion mutants bound to glutathione sepharose beads, as indicated. Bound proteins were 841 
analysed by western blotting using an anti-Flag antibody. Input corresponds to 1/40 of the cell 842 
extract used for the GST-pulldown.   843 
 844 
Figure 6. Probing EBNA1 peptide arrays for RCC1 interaction sites. (A) Arrays of 845 
immobilized peptide spots of overlapping 25-mer peptides covering the entire sequence of 846 
EBNA1 (including the GA repeat) were probed with recombinant GST-RCC1 (a), GST-847 
RCC1Δ1-20 (b), GST-RCC1 1-20 (c) and GST (d) and revealed by incubation with an anti-848 
GST antibody. Light blue, blue and red rectangles respectively indicate low, medium and high 849 
affinity binding to contiguous interacting peptides. The limits of the interacting regions are 850 
indicated for each rectangle by the positions of the first aa of the first peptide and the last aa 851 
of the last peptide. * Note: the GST-RCC1Δ1-20 array shown in the figure is the result of a 852 
longer exposure compared to the other array images. (B) Schematic representation of EBNA1 853 
and its interaction regions with RCC1 as determined by the peptide array. Boxes along the 854 
linear depiction indicate binding (strong, intermediate or weak). Abbreviations are similar to 855 
those indicated in Figure 1.  *indicates the position of the protein kinase 2 (CK2) binding 856 
sites. USP7: Ubiquitin Specific Peptidase 7. Positions of the AT-hook regions (between aa 40 857 
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to 53 and 326 to 358) are indicated in green. 858 
 859 
Figure 7. Dynamic localization of EBNA1 and RCC1 throughout the cell cycle. HeLa 860 
cells coexpressing RFP-EBNA1 and EGFP-RCC1 were observed by confocal microscopy at 861 
different stages of the cell cycle as indicated. Images show single confocal z-section. Trans: 862 
Transmission.  863 
 864 
Figure 8. FRET analysis of EGFP-EBNA1 and RFP-RCC1 interaction at different 865 
stages of the cell cycle. HeLa cells coexpressing EGFP-EBNA1 and RFP-RCC1 were 866 
analysed by Förster resonance energy transfer (FRET) at different stages of the cell cycle as 867 
indicated. Analyses were performed using ImageJ software ‘FRET Analyzer’. Imaged cells 868 
were selected on the basis of both fusion proteins expression levels being similar to that found 869 
in single transfected cells used for spectral leakage calculation. Results are presented as three 870 
images, considering low, average or high spectral leakage level (noted as low, medium or 871 
high cut-off). High cut-off images are the most representative of the FRET signals. The FRET 872 
signal is represented using a firescale gradient: blue: no FRET signal, yellow: maximum 873 
FRET signal. 874 
 875 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
DBD / DimerGAr
1







































































































































GFP-EBNA1              
***
ns
Figure 1 Click here to download Figure Deschamps et al Fig 1.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82



















































Figure 2 Click here to download Figure Deschamps et al Fig 2 JGV.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
DBD / DimerGAr
1






















































A CBS3 CBS1 CBS2
B
C
Figure 3 Click here to download Figure Deschamps et al Fig 3 JGV.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82









































1          2         3         4         5
DBD / DimerGAr
1
































Figure 4 Click here to download Figure Deschmaps et al Fig 4 JGV.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
N CRCC1 7 repeats
(M)SPKRIAKRRSPPADAIPKSKKVKVSH
P P



















































































1 2 3 4 5 6 7 8 9
Figure 5 Click here to download Figure Deschamps et al Fig 5.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82













































































Figure 6 Click here to download Figure Deschamps et al Fig 6.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50




Figure 7 Click here to download Figure Deschamps et al Fig 7.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
-                                                 +
FRET intensity
Interaction




Figure 8 Click here to download Figure Deschamps et al Fig 8.eps 
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Thu, 15 Dec 2016 12:14:50
SUPPLEMENTARY MATERIAL 
 
Legend to supplementary Figure 1.  
The N-terminal region of RCC1 (MSPKRIAKRRSPPADAIPKS) contains 6 positively 
charged residues and one negatively charged residue. The C-terminal tail of EBNA1, from 
residue 610 to 641 has 14 negatively charged residues, interspersed with glycines and no 
positively charged residues. The stretch of residues in common between the EBNA1 peptides 
that span R396 to E435, which interact strongly with both RCC1 and RCC1 1-20, are aa 411 
to 420 (EADYFEYHQE) and referred to below as the core region. This region contains 4 
negatively-charged residues but is surrounded by residues of negative and positive charge.  
To determine the key residues in this binding site, a new array was generated spanning the 
EBNA1 sequence from residue 401 to 430 and including a series of mutated peptides 
comprising: sequential Ala replacement peptides (Ala scanning); N- and C-terminal deletion 
peptides; Ala replacement of the four negatively-charged residues of the core region; and the 
core region alone (as shown). This array was probed with GST-RCC1 1-20. Sequential 
replacement of residues with Ala showed no (or little) reduction in binding until residue 413 
(peptide 16). Ala replacement of DYFEY and Q of the core all showed substantial reduction 
in binding by GST-RCC1 1-20, with replacement of F415 showing the weakest binding with 
these single replacements (peptides 16 to 20 and 22). Further Ala replacement to residue 430 
(peptides 23 to 33) showed no reduction in binding, confirming the span of the core binding 
region. Replacement of the four charged residues (E411, D413, E416, E420) in the core 
completely abrogated binding (peptide 34), while binding to the 10 residue core alone 
(peptides 63 and 64) was as strong as binding to the full-length 25mer peptides incorporating 
this region. Sequential N-terminal deletion of the 25mer peptide revealed reduced binding 
upon deletion of Y414 of the core and no binding with further N-terminal deletion, again 
revealing F415 to be  a critical residue in binding (peptides 43 to 48). It is noteworthy that this 
15mer deleted up to F415 still has 3 glutamate (negative) residues, but does not bind GST-
RCC1 1-20. Sequential C-terminal deletion of the 25mer peptide (peptides 59 to 62) revealed 
reduced binding upon deletion of E420, confirming the C-terminal limit of the core region. 
These data show that residues 413 to 420 (DYFEYHQE) of EBNA1 represent a tight binding 
region of the first 20 residues of RCC1, that the negatively charged residues in this region are 
essential for the interaction, and that F415 and Y414 are also key in the interaction. 
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Supplementary Figure 1. Characterization of amino acids within EBNA1 region 401 to 
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Construction name Primers for gateway cloning 
pDONR-EBNA1 5’-GGGGACAACTTTGTACAAAAAAGTTGGCATGACAGGACCTGCAAATGGCC-3’ 
5’-GGGGACAACTTTGTACAAGAAAGTTGGTCACTCCTGCCCTTCCTCAC-3’ 
pDONR-EBNA1 8-410 5’-GGGGACAACTTTGTACAAAAAAGTTGGCATGACAGGACCTGCAAATGGCC-3’ 
5’-GGGGACAACTTTGTACAAGAAAGTTGGTCACCCTACAGGGTGGAAAAATGG-3’ 
pDONR-EBNA1 381-Cter 5’-GGGGACAACTTTGTACAAAAAAGTTGGCATGCCCAGGAGTCCCAGTAGTCAG-3’ 
5’-GGGGACAACTTTGTACAAGAAAGTTGGTCACTCCTGCCCTTCCTCAC-3’ 
pDONR-RCC 1-20 5’-GGGGACAACTTTGTACAAAAAAGTTGGCATGTCACCCAAGCG-3’ 
5’-GGGGACAACTTTGTACAAGAAAGTTGGTTAGCTTTTGGGGATGGC-3’ 
pDONR-EBNA1 8-92nls 5’-GGGGACAACTTTGTACAAAAAAGTTGGCATGCCTAAGAAGAAGCGCAAAGTC 
GGACCTGGAAATGGCC-3’ 
3’-GGGGACAACTTTGTACAAGAAAGTTGGTCATCCTGCTCCTGTTCCACCG-5’ 
pDONR-EBNA1 323-410 5’-GGGGACAACTTTGTACAAAAAAGTTGGCATGGAGCAGGAGGTGGAGGC-3’  
5’-GGGGACAACTTTGTACAAGAAAGTTGGTCACCCTACAGGGTGGAAAAATGG-3’ 
 Primers for Infusion cloning 
pRFP-N1-EBNA1 5’-GGCAGGAGAAGGATCCGGCCTCCTCCGAGGACGTCATC-3’  
5’-TCTAGAGTCGCGGCCGCGCAGAATTCTTAGGCGCCGGTGGA-3’ 
pRFP-C1-EBNA1 5’-CGCTAGCGCTACCGGTGAGCTCGGATCCATGGCCTCC 3’ 
5’-TCCAGGTCCTGTATCTGCAGTTCTATAGGCGCCGGTGGAGTG 3’ 










 Primers for site directed mutagenesis 
peGFP-N1-EBNA1 Δ40-53  5'-GGGGCTCCTGGATGGTTATCACCCCCTCTT-3' 
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5'-AAGAGGGGGTGATAACCATCCAGGAGCCCC-3' 
peGFP-N1-EBNA1 Δ326-358 5'-CACGGTGGAACAGGAGAAAGAGCCAGGGGG-3' 
5'-CCCCCTGGCTCTTTCTCCTGTTCCACCGTG-3' 
peGFP-N1-EBNA1 Δ411-420 5’-CCACCCTGTAGGGGGTGGCCCAGATGGTG-3’ 
5’-CACCATCTGGGCCACCCCCTACAGGGTGG-3’ 
pDEST15-RCC1 Δ1-20 5‘-GTACAAAAAAGTTGGCATAGCTAAAAGAAGGTCCC-3’ 
5’- GAGACCTTCACCTTCTTATCTGCTGGGG-3’ 
pDEST15-RCC1 Δ1-5 5‘-GTACAAAAAAGTTGGCATAGCTAAAAGAAGGTCCC-3’ 
5’-GGGACCTTCTTTTAGCTATGCCAACTTTTTTGTAC-3’ 
pDEST15-RCC1 Δ6-10 5’-GCATGTCACCCAAGCGCTCCCCCCCAGCAGATGC-3’ 
5’ GCATCTGCTGGGGGGGAGCGCTTGGGTGACATGC-3’ 
pDEST15-RCC1 Δ11-15 5’-GCATAGCTAAAAGAAGGGCCATCCCCAAAAGC-3’ 
5’- GCTTTTGGGGATGGCCCTTCTTTTAGCTATGC-3’ 
pDEST15-RCC1 Δ16-20 5’-CCCCAGCAGATAAGAAGGTGAAGGTCTC-3’ 
5’- GAGACCTTCACCTTCTTATCTGCTGGGG-3’ 
 
Supplementary table : Oligonucleotides used for PCR-amplifications, Infusion cloning and Site-
Directed mutagenesis. 
 
